Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 235-546-0 | CAS number: 12270-13-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
In an acute oral toxicity study (Grundler, 1981) conducted with the target substance (18.3%) in a mixture, the combined oral LD50 was determined to be 3.680 mg/kg bw. By extrapolating the concentration of 18.3% of the target substance within the mixture to 100% the calculated combined LD50 value would be 675 mg/kg bw.
In a second acute oral toxicity study (Hackenberg, 1977) conducted with the target substance (20%) in a mixture, the combined oral LD50 was determined to 2.060 mg/kg bw. By extrapolating the concentration of 20% of the target substance within the mixture to 100% the calculated LD50 value would be 412 mg/kg bw for both sexes.
Supporting information is provided by the study by Katz, 1970 in a read-across approach to get information on the toxicity of the chromophore itself. In this study, the acute oral LD50 in rats was determined to be 3.700 mg/kg bw in males and 4.300 mg/kg bw in females. Details on the read-across rational are provided in section 13.
No data regarding the target substance was available for acute toxicity via the inhalation route. Furthermore, as the substance is only marketed as an aqueous solution containing significant concentrations of free acetic acid as stabiliser, this route of exposure is not relevant and animal testing is not considered to be in accordance with animal welfare regulations. Thus, available data from the chloride salt of the target substance was used in a read-across approach solely to get information on the toxicity of the chromophore itself. Based on the results obtained from an in vivo acute inhalation study, the combined LC0 value of the source substance can be considered to be 1.0408 mg/L.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- 1981-10-13 to 1981-12-17
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- test procedure in accordance with national standard methods
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Deviations:
- no
- GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Wiga, Sulzfeld, Germany
- Age at study initiation: ca. 12 weeks old
- Housing: 5 animals were kept in per cage (V-II-A-steel cages)
- Fasting period before study: 16 hours before treatment animals received no diet
- Diet (e.g. ad libitum): SSNIFF R from SSNIFF Versuchstierdiaeten, Soest, Germany; ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: at least 7 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20 - 26
- Humidity (%): 45 -75
- Air changes (per hr): not identified
- Photoperiod (hrs dark / hrs light): 12 / 12
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
- MAXIMUM DOSE VOLUME APPLIED: 10 mL/kg bw
- Doses:
- 2150, 3160, 4640 and 6810 mg/kg bw
- No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations: <15 min, 15 min, 30 min, 1 hour, 2 hours, 4 hours, 5 hours after application. Afterwards once per day the clinical signs were recorded and twice per day mortality was checked.
- Frequency of weighing: before application, and on days 3, 7 and 13 after application
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs - Statistics:
- Probit analysis [Finney D.J., 1971; Cambridge University Press Vol. 3]
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 2 790 mg/kg bw
- Based on:
- test mat.
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 4 640 mg/kg bw
- Based on:
- test mat.
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 3 680 mg/kg bw
- Based on:
- test mat.
- Mortality:
- Please see table 1 in the box "Any other information on results incl. tables".
- Clinical signs:
- Clincal signs were observed in all dose groups. Please see table 2 in the box "Any other information on results incl. tables".
- Body weight:
- No effects on body weight development.
- Gross pathology:
- Sacrificed animals without any findings in organs.
Moridund or dead animals (4640/6810 mg/kg bw): Hyperemia, blue colouration of the instestinal mucosa, partly atonic, dilated, several organs, muscles and fat tissue coloured blue. - Interpretation of results:
- Category 4 based on GHS criteria
- Conclusions:
- In an acute oral toxicity study, the combined LD50 of the test item was determined to be 3680 mg/kg bw in female and male Sprague-Dawley rats. By extrapolating the concentration of 18.3% of the target substance within the mixture to 100% the calculated LD50 value would be 675 mg/kg bw and classification as Acute Tox 4, H302 is warranted in accordance with the CLP regulation.
- Executive summary:
In an acute oral toxicity study, the combined LD50 of the test item was determined to be 3680 mg/kg bw in female and male Sprague-Dawley rats. By extrapolating the concentration of 18.3% of the target substance within the mixture to 100% the calculated LD50 value would be 675 mg/kg bw and classification as Acute Tox 4, H302 is warranted in accordance with the CLP regulation.
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- 1977-09-29
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Weight at study initiation: Mean: males 147 g, females 133 g
- Fasting period before study: ca. 16 hours before application
- Housing: cages: MAKROLON type III cages (max. 5 rats),
- Diet (e.g. ad libitum): ad libitum, standard pellet diet for rats and mice
- Water (e.g. ad libitum): ad libitum
- Acclimation period: min. 3, max. 7 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): ca. 21-23 °C
- Humidity (%): ca. 50-70%
- Photoperiod (hrs dark / hrs light): 12/12 - Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
- MAXIMUM DOSE VOLUME APPLIED: 10.0 mL/kg bw
DOSAGE PREPARATION (if unusual): immediately prior administration, emulsion and suspension during application was stirred on a magnetic stirrer
- Doses:
- 681, 1000, 1470, 2150, 3160, 4640 and 10000 mg/kg bw
- No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations: < 15 min, 15 min, 30 min, 1 h, 2 h, 4 h, 5 h and 24 h after application, then daily at least 1 time until day 14 after application, body weight: prior to administration
- Necropsy of survivors performed: yes - Statistics:
- Determination of LD50-value: Dose-lethality-time relationship, Probit-Analysis according to FINNEY separated for male and female rats and together for 14-day observation time
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 2 090 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- >= 1 650 - <= 2 660
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 2 050 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- >= 1 590 - <= 2 650
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 2 060 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- >= 1 720 - <= 2 470
- Mortality:
- See Table 1 in box "Any other information on results incl. tables".
- Clinical signs:
- 0.681 g/kg: urine dyed blue-green, reduced amount of feces
1.00 to 1.47 g/kg: urine dyed blue-green, reduced amount of feces, apathy, breathing in bursts, breathing snapping and partially wheezing
2.15 to 10.0 g/kg: symptoms started immediately until 30 min after application: apathy, eyelids narrow to closed, lifted fur, breathing snapping, intermittently and gasping, reduced muscle tone, reduced feces, urine blue-green stained, in some rats a strongly distended abdomen was observed. The majority of survived rats was without findings 3 days after application. - Body weight:
- No effects observed, normal body weight gain development
- Gross pathology:
- Spontaneously died rats: systemic blue staining of all organs.
Killed rats at the end of observation period: without findings. - Interpretation of results:
- Category 4 based on GHS criteria
- Conclusions:
- In conclusion, in an acute oral toxicity study the LD50 value was 2090 mg/kg bw for male rats, 2050 mg/kg bw for female rats and 2060 mg/kg bw for both sexes. By extrapolating the concentration of 20% of the target substance within the mixture to 100% the calculated LD50 value would be 412 mg/kg bw for both sexes and classification as Acute Tox 4, H302 is warranted in accordance with the CLP regulation.
- Executive summary:
In an acute oral toxicity study, groups of fasted Sprague-Dawley rats (5/sex) were given a single oral dose of the test item (20% purity) suspended in water at doses of 0.681, 1.00, 1.47, 2.15, 3.16, 4.64 and 10.0 g/kg bw and were observed afterwards for 14 days. Symptoms as reduced feces amount, apathy, abnormal breathing was observed at lower doses. In higher doses (2.15 to 10.0 g/kg) symptoms started immediately until 30 min after application. Apathy, eyelids narrow to closed, piloerection, breathing snapping, intermittently and gasping, reduced muscle tone, reduced feces, urine blue-green stained and in some rats a strongly distended abdomen was observed. The majority of survived rats was without findings 3 days after application. No effects in body weight gain was observed. There were no pathological findings except the blue colouring of all organs in spontaneously died rats.
Based on the mortality, the LD50 value was determined with 2090 mg/kg bw for male rats, 2050 mg/kg bw for female rats and 2060 mg/kg bw for both sexes.
By extrapolating the concentration of 20% of the target substance within the mixture to 100% the calculated LD50 value would be 412 mg/kg bw for both sexes and classification as Acute Tox 4, H302 is warranted in accordance with the CLP regulation.
Referenceopen allclose all
Table 1: Mortality | |||||
Dose (mg/kg bw) | 6810 | 4640 | 3160 | 2150 | |
Number of animals, male | 5 | 5 | 5 | 5 | |
Dead animals after | |||||
1 hour | 0 | 0 | 0 | 0 | |
1 day | 2 | 0 | 0 | 0 | |
2 days | 4 | 2 | 0 | 0 | |
7 days | 4 | 3 | 0 | 0 | |
14 days | 4 | 3 | 0 | 0 | |
Number of animals, female | 5 | 5 | 5 | 5 | |
Dead animals after | |||||
1 hour | 0 | 0 | 0 | 0 | |
1 day | 4 | 4 | 0 | 1 | |
2 days | 5 | 4 | 0 | 1 | |
7 days | 5 | 5 | 2 | 1 | |
14 days | 5 | 5 | 3 | 1 |
Table 2: Signs of toxicity | |||||
Dose (mg/kg bw) | 6810 | 4640 | 3160 | 2150 | |
Clinical signs, male | |||||
Dyspnoe | 15M-6D | 15M-7D | 30M-3D | 30M-5H | |
Abnormal breething | 7D | ||||
Apathy | 15M-6D | 15M-2D | 30M-3D | 30M-5H | |
Increased spontaneous activity | 3D-7D | ||||
Prone Position | 1H | ||||
Ataxia | 15M-6D | 15M-7D | 30M-3D | 30M-5H | |
Tremble | 30M-2D | 1H-2D | 1H | ||
Spastic gait | 2D-3D | 2D-7D | |||
Blue feces | 5H | 5H | 5H | ||
Blue urine | 1H-3D | 4H-3D | 5H-3D | 1D-2D | |
Piloerection | 4H-6D | 2H-7D | 2H-3D | 4H-2D | |
Diarrhoea | 5H | 5H | 5H | ||
Salivation | 4H-5H | ||||
Ptosis | 1H-2D | 1H-2D | |||
Cachexia | 3D | ||||
Poor general condition | 15M-6D | 15M-7D | 30M-3D | 30M-5H | |
Clinical signs, female | |||||
Dyspnoe | 15M-1D | 15M-3D | 30M-10D | 30M-1D | |
Apathy | 15M-1D | 15M-3D | 30M-10D | 30M-1D | |
Aggressive behaviour | 3D-7D | ||||
Prone Position | 1H | 1H-1D | |||
Ataxia | 15M-1D | 15M-3D | 30M-10D | 30M-5H | |
Tremble | 30M-1D | 1H-2D | 1H-8D | 1H | |
Spastic gait | 2D-3D | 2D-8D | |||
Blue feces | 5H | 5H | 5H | ||
Blue urine | 1H-1D | 4H-3D | 5H-3D | 1D-2D | |
Piloerection | 4H-1D | 4H-3D | 2H-10D | 2H-3D | |
Exsiccoseis | 1D-2D | 8D | |||
Salivation | 4H-5H | ||||
Ptosis | 1H-1D | ||||
Cachexia | 3D | 3D | |||
Diarrhoea | 5H | 5H | 5H | ||
Poor general condition | 15M-1D | 15M-3D | 30M-10D | 30M-1D |
D=day
H=hour
M=Minute
Table 1: Mortality
Doses g/kg | Application volume mL/kg | Concentration mg/mL | 1 h | 24 h | 48 h | 7 days | 14 days | |||||
male | female | male | female | male | female | male | female | male | female | |||
0.681 | 10.0 | 68.1 | - | 0 | - | 0 | - | 0 | - | 0 | - | 0 |
1.00 | 10.0 | 100 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 1 |
1.47 | 10.0 | 147 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 1 |
2.15 | 10.0 | 215 | 0 | 0 | 0 | 1 | 2 | 2 | 4 | 2 | 4 | 2 |
3.16 | 10.0 | 316 | 0 | 0 | 0 | 1 | 2 | 3 | 3 | 4 | 3 | 4 |
4.64 | 10.0 | 464 | 0 | 0 | 5 | 4 | 5 | 5 | 5 | 5 | 5 | 5 |
10.0 | 10.0 | 909 | - | 4 | - | 5 | - | 5 | - | 5 | - | 5 |
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 412 mg/kg bw
- Quality of whole database:
- Study conducted equivalent/similar to OECD TG 401
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Justification for type of information:
- For justification of read-across please refer to the read-across report attached to IUCLID section 13.
- Reason / purpose for cross-reference:
- read-across source
- Duration of exposure:
- h
- Sex:
- male/female
- Dose descriptor:
- LC0
- Effect level:
- 1.041 mg/L air
- Based on:
- test mat.
- Exp. duration:
- 1 h
- Key result
- Sex:
- male/female
- Dose descriptor:
- LC50
- Effect level:
- > 1.041 mg/L air
- Based on:
- test mat.
- Exp. duration:
- 1 h
- Mortality:
- No mortality observed
- Clinical signs:
- other: no signs of toxicity observed
- Body weight:
- The body weight gain was subnormal in both males and females.
males: 40.7 g (30-57 g)
females: 18.6 g (10-24 g) - Gross pathology:
- not specified
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Under the conditions of the test, the LC50 of the test item is greater than 1.0408 mg/L.
- Executive summary:
In an acute inhalation toxicity study, groups of young adult Osborne-Mendel rats (5/sex) were exposed by inhalation route to the test item in air for 1 hour to the whole body at a mean concentration of 1.0408 mg/L. Animals then were observed for 14 days. There were no treatment related clinical signs nor mortality, though the body weight gain was sub normal. Based on these results, the LC50 of the test item is greater than 1.0408 mg/L.
The test item is considered to be of low toxicity and does not warrant for classification.
This information is used in a read-across approach in the assessment of the target substance.
For justification of read-across please refer to the attached read-across report (see IUCLID section 13).
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LC50
- Value:
- 1 040.8 mg/m³
- Quality of whole database:
- Comparable to guideline study with acceptable restrictions
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
In an acute oral toxicity study (Grundler, 1981) conducted with the target substance (18.3%) in a mixture, the combined oral LD50 was determined to be 3680 mg/kg bw. By extrapolating the concentration of 18.3% of the target substance within the mixture to 100% the calculated LD50 value would be 675 mg/kg bw.
In a second acute oral toxicity study (Hackenberg, 1977) conducted with the target substance (20%) in a mixture, the combined oral LD50 was determined to 2060 mg/kg bw. By extrapolating the concentration of 20% of the target substance within the mixture to 100% the calculated LD50 value would be 412 mg/kg bw for both sexes.
Supporting information is provided with the study by Katz, 1970 in a read-across approach to get information of the toxicity of the chromophore itself. In this study, the acute oral LD50 in rats was determined to be 3700 mg/kg bw in males and 4300 mg/kg bw in females. Details on the read-across rational are provided in section 13.
No data regarding the target substance was available for acute toxicity via the inhalation route. Thus, available data from the chloride salt of the target substance was used in a read-across approach solely to get information on the toxicity of the chromophore itself. Based on the results obtained from an in vivo acute inhalation study, the combined LC0value of the source substance can be considered to be 1.0408 mg/L. As the substance is only marketed as an aqueous solution containing significant concentrations of free acetic acid as stabiliser, this route of exposure is not relevant and animal testing is not considered to be in accordance with animal welfare regulations.
Justification for classification or non-classification
Based on the available data, the target substance does warrant classification as Acute Tox. 4, H302 in accordance to regulation (EC) No 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.